½ÃÀ庸°í¼­
»óǰÄÚµå
1751302

¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

U.S. Breath Analyzers Market Size, Share & Trends Analysis Report By Technology (Fuel Cell, Semiconductor Sensor, Infrared Spectroscopy), By Application, By End Use, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 110 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 31¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2030³âÀÇ CAGRÀº 15.64%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾ËÄÚ¿Ã ³²¿ëÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¹ý ÁýÇà ±â°ü, Çб³, ½ºÆ÷Ã÷, »ç¹«½Ç ¹× ±âŸ ±â°ü¿¡¼­ È£Èí ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â °ÍÀÌ ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¾Ï, °áÇÙ, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)°ú °°Àº Áúº´ÀÇ Á¶±â Áø´ÜÀº Ä¡·á ¼º°ø·ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. È£Èí ºÐ¼®±â´Â È£Èí ³»¿ëÀ» ±â¹ÝÀ¸·Î ½Å¼ÓÇÑ 1Â÷ Áø´ÜÀ» Á¦°øÇÕ´Ï´Ù.

±Ý¿¬ Ȱµ¿¿¡¼­ È£Èí ÀÏ»êȭź¼Ò(CO) ÃøÁ¤°ú °°Àº °³ÀÎ¿ë ¿ëµµ Áõ°¡´Â ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, COVID-19 ÆÒµ¥¹Í ±â°£ Áß ´ëºÎºÐÀÇ »ó¾÷ Ȱµ¿ÀÌ ÁߴܵǸ鼭 È£Èí ºÐ¼®±â ½ÃÀåÀº ħü±â¸¦ °æÇèÇß½À´Ï´Ù. »ý»ê ±âÁöÀÇ Æó¼â¿Í °ø±Þ¸Á Áß´ÜÀ¸·Î ÀÎÇØ ½ÃÀåÀÇ ÁÖ¿ä ¼öÀÔ¿ø ÀÎ ´ëºÎºÐÀÇ ÃÖÁ¾»ç¿ëÀÚ°¡ ¿µÇâÀ» ¹Þ¾Æ È£Èí ºÐ¼®±â ÆÇ¸Å°¡ °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª COVID-19 ÆÒµ¥¹ÍÀº ¾÷°è Àü¹Ý¿¡ °ÉÃÄ ÀÏ·ÃÀÇ º¯È­¸¦ °¡Á®¿Ô½À´Ï´Ù.

¿¹¸¦ µé¾î ¹Ì±¹ ±³ÅëºÎ´Â ÇâÈÄ ½ÅÂ÷¿¡ ¾ËÄÚ¿Ã °¨Áö½Ä ½Ãµ¿ ¹öưÀ» ÀåÂøÇÏ¿© ¾ËÄÚ¿ÃÀÌ °¨ÁöµÇ¸é ÁÖÇàÀÌ ºÒ°¡´ÉÇϵµ·ÏÇÒ °ÍÀ̶ó°í ¹ßÇ¥Çß½À´Ï´Ù. µû¶ó¼­ ¿¹Ãø ±â°£ Áß ½ÃÀåÀº Âü½ÅÇϰí Çõ½ÅÀûÀÎ ±â¼úÀÇ µµÀÔ°ú ½ÅÁ¦Ç° Ãâ½Ã¸¦ ÅëÇØ ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ºñ°¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Àü¿°¼º ÁúȯÀÇ ³ôÀº ºñÀ²°ú ÇÔ²² Àü ¼¼°è¿¡¼­ ÀÌÁßÀÇ Áúº´ ºÎ´ãÀ» ¾ß±âÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ Áúº´À» Á¶±â¿¡ ¹ß°ßÇϰí ȯÀÚ¸¦ ÀûÀýÇÑ Ä¡·á ä³Î·Î ¾È³»ÇÒ ¼ö ÀÖ´Â Àú·ÅÇÏ°í ½±°Ô ±¸ÇÒ ¼ö ÀÖ´Â °­·ÂÇÑ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ À½ÁÖ¿îÀü°ú ¾à¹° ³²¿ëÀ¸·Î ÀÎÇÑ ±³Åë»ç°í Áõ°¡·Î ÀÎÇØ È£Èí ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ´Ù¾çÇÑ È­ÇÕ¹°ÀÇ Á¸À縦 ¸ð´ÏÅ͸µÇϰí È£Èí »ùÇÃÀÇ Ç÷Áß ¾ËÄÚ¿Ã ³óµµ¸¦ ÃøÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®ÀÔ´Ï´Ù. È£Èí ºÐ¼®±â´Â ¾ËÄڿðú ¸ÞÆ¿±â¸¦ °¡Áø ´Ù¸¥ È­ÇÕ¹°À» ±¸º°ÇÏÁö ¸øÇÏ¿© ºÎÁ¤È®ÇÑ °á°ú°¡ ³ª¿Ã ¼ö ÀÖ½À´Ï´Ù. ÀϺΠ¾ËÄÚ¿Ã °Ë»ç±â Áß¿¡´Â ¿¡Æ¿¾ËÄڿûӸ¸ ¾Æ´Ï¶ó À¯»çÇÑ ºÐÀÚ±¸Á¶¸¦ °¡Áø È­ÇÕ¹°À» ÀνÄÇÏ´Â °Íµµ ÀÖ½À´Ï´Ù. ÀÌó·³ È£Èí ºÐ¼®±â¿¡ ´ëÇÑ Á¤È®µµ ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ È£Èí ºÐ¼®±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¿¬·áÀüÁö ±â¼ú ºÎ¹®Àº 2024³â 33.89%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÎ¹®Àº ³ôÀº Á¤È®µµ, ¾ÈÁ¤¼º, È£Èí Áß ¿¡Åº¿Ã ¹× ¾Æ¼¼Åæ°ú °°Àº ƯÁ¤ ¹ÙÀÌ¿À¸¶Ä¿¸¦ °¨ÁöÇÏ´Â ¹Î°¨µµ°¡ ÀÌ·¯ÇÑ ¼ºÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
  • Àû¿Ü¼±(IR) ºÐ±¤¹ýÀº ¿¹Ãø ±â°£ Áß 16.24%ÀÇ °¡Àå ºü¸¥ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº È£Èí Áß Æ¯Á¤ °¡½º ¹× È­ÇÕ¹°À» °¨ÁöÇÏ´Â Á¤È®µµ°¡ ³ô±â ¶§¹®ÀÔ´Ï´Ù.
  • ¾ËÄÚ¿Ã °¨Áö ºÐ¾ß´Â À½ÁÖ¿îÀü ¹æÁö ¹× Ä¡¾È °­È­¸¦ À§ÇÑ ¹ý ÁýÇà ±â°üÀÇ ³ë·ÂÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹Ì±¹ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼¼ºÐÈ­¿¡¼­´Â À½ÁÖ¿îÀü(DUI)¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦·Î ÀÎÇØ ¹ý ÁýÇà ±â°ü ºÎ¹®ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå µ¿Çâ°ú Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå ºÐ¼® Åø : PESTL
    • Á¤Ä¡¿Í ¹ý·ü
    • °æÁ¦¿Í »çȸ
    • Å×Å©³î·¯Áö
    • ȯ°æ
  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå ºÐ¼® Åø : PorterÀÇ »ê¾÷ ºÐ¼®
  • ±ÔÁ¦ÀÇ °³¿ä
  • °¡°Ý ºÐ¼®
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ±â¼ú ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • 2024³â°ú 2030³âÀÇ µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¼úº°
  • ¿¬·áÀüÁö ±â¼ú
  • ¹ÝµµÃ¼ ¼¾¼­
  • Àû¿Ü¼±(IR) ºÐ±¤¹ý
  • ±âŸ

Á¦5Àå ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • 2024³â°ú 2030³âÀÇ µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¿ëµµº°
  • ¾à¹° ³²¿ë ŽÁö
  • ¾ËÄڿà ŽÁö
  • ÀÇ·á ¿ëµµ

Á¦6Àå ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : º¯µ¿ ºÐ¼®
  • ¹Ì±¹ÀÇ È£±â ºÐ¼®±â ½ÃÀå : ºÎ¹® ´ë½Ãº¸µå
  • 2024³â°ú 2030³âÀÇ µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÃÖÁ¾ ¿ëµµº°
  • ¹ýÁýÇà±â°ü
  • °³ÀÎ
  • ±âŸ

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ ºÐ·ù
  • 2024³â ±â¾÷ ½ÃÀå Á¡À¯À²/Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ °³¿ä/¸®½ºÆ®
    • Dragerwerk AG &Co. KGaA
    • Lifeloc Technologies, Inc.
    • Quest Products, LLC.
    • Intoximeters
    • Alcohol Countermeasure Systems Corp.
    • AK GlobalTech Corp.
    • PAS Systems International, Inc
    • BACtrack
    • Lion Laboratories
    • Advanced Safety Devices
    • MPD, Inc.
    • Abbott Rapid Diagnostics(formerly known as Alere)
    • AlcoPro
    • GenWorks Health Pvt. Ltd.
KSA

U.S. Breath Analyzers Market Growth & Trends:

U.S. breath analyzers market size is expected to reach USD 3.13 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.64% from 2025 to 2030. Growing demand for breath analyzers from law enforcement agencies and other institutions such as schools, sports, and offices to minimize alcohol abuse is a major market driver. Early diagnosis of diseases such as cancer, tuberculosis, and Chronic Obstructive Pulmonary Disease (COPD) plays a key role in the success rate of their treatment. Breath analyzers offer a quick primary diagnosis based on exhaled air contents.

Growing applications in private use such as measurement of breath Carbon Monoxide (CO) in smoking cessation activities are expected to boost market growth during the forecast period. During the COVID-19 pandemic, the breathalyzer market experienced a downturn as most commercial activities were halted. Owing to a close in production units and an interruption in the supply chain, most main revenue-generating end-users of the market were impacted, resulting reduction in sales of breath analyzers. However, the COVID-19 pandemic brought about a series of changes across industries.

For instance, the U.S. Department of Transportation announced that in the future new cars will be equipped with alcohol-sensing start buttons, which will prevent them from moving if it detects alcohol. Hence, it is expected that the market will witness the introduction of novel, innovative technologies, and new product launches during the forecast period, in turn, positively impacting growth. The growing prevalence of noncommunicable illnesses, along with the high rate of infectious diseases, is driving the double disease burden across the world. Hence, there is a significant demand for cheap, accessible, and ruggedized diagnostic tools that detect diseases early and direct patients to the right treatment channels.

Furthermore, the growing number of road accidents due to drunk driving and drug abuse has augmented the demand for breath analyzers, as these devices help monitor the presence of different compounds and measure the blood alcohol content in a breath sample. Sometimes breath analyzers provide inaccurate results, failing to differentiate alcohol from any other chemical compound that holds a methyl group structure. Some alcohol testing machines recognize not only ethyl alcohol but also any compound with a similar molecular structure. Thus, accuracy concerns pertaining to breath analyzers are expected to limit market growth.

U.S. Breath Analyzers Market Report Highlights:

  • The fuel cell technology segment held the largest revenue share of 33.89% in 2024. Its high accuracy, stability, and sensitivity in detecting specific biomarkers such as ethanol and acetone in breath drive this growth.
  • Infrared (IR) spectroscopy is anticipated to witness the fastest CAGR of 16.24% over the forecast period. The growth is attributed to its precision in detecting specific gases and compounds in exhaled breath.
  • The alcohol detection segment dominated the U.S. market due to increasing efforts in law enforcement to deny drunk driving and enhance public safety.
  • The law enforcement agencies segment held the largest revenue share in the market, driven by stringent regulations against driving under the influence (DUI).

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Volume Model Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. Breath Analyzers Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Technology segment outlook
      • 2.1.2.2. Application segment outlook
      • 2.1.2.3. End Use segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Raising alcohol and drug abuse
      • 3.3.1.2. Stringent government regulations
      • 3.3.1.3. Increasing use of breath analyzers in detecting various diseases
      • 3.3.1.4. Technological Advancements
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Accuracy Issues
    • 3.3.3. Market Opportunity Analysis
    • 3.3.4. Market Challenges Analysis
  • 3.4. U.S. Breath Analyzers Market Analysis Tools: PESTL
    • 3.4.1. Political & Legal
    • 3.4.2. Economic & Social
    • 3.4.3. Technology
    • 3.4.4. Environmental
  • 3.5. U.S. Breath Analyzers Market Analysis Tools: Porter's
      • 3.5.1.1. Competitive rivalry
      • 3.5.1.2. Threat of new entrants
      • 3.5.1.3. Bargaining power of buyers
      • 3.5.1.4. Bargaining power of suppliers
      • 3.5.1.5. Threat of substitutes
  • 3.6. Regulatory Overview
  • 3.7. Pricing Analysis
  • 3.8. COVID-19 Impact

Chapter 4. U.S. Breath Analyzers Market: Technology Estimates & Trend Analysis

  • 4.1. U.S. Breath Analyzers Market: Technology Movement Analysis
  • 4.2. U.S. Breath Analyzers Market: Technology Segment Dashboard
  • 4.3. Technology Movement & Market Share Analysis, 2024 & 2030
  • 4.4. U.S. Breath Analyzers Market Estimates & Forecast, by Technology
  • 4.5. Fuel Cell Technology
    • 4.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 4.6. Semiconductor Sensor
    • 4.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 4.7. Infrared (IR) Spectroscopy
    • 4.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 5. U.S. Breath Analyzers Market: Application Estimates & Trend Analysis

  • 5.1. U.S. Breath Analyzers Market: Application Movement Analysis
  • 5.2. U.S. Breath Analyzers Market: Application Segment Dashboard
  • 5.3. Application Movement & Market Share Analysis, 2024 & 2030
  • 5.4. U.S. Breath Analyzers Market Estimates & Forecast, by Application
  • 5.5. Drug Abuse Detection
    • 5.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 5.6. Alcohol Detection
    • 5.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 5.7. Medical Applications
    • 5.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Breath Analyzers Market: End Use Estimates & Trend Analysis

  • 6.1. U.S. Breath Analyzers Market: End Use Movement Analysis
  • 6.2. U.S. Breath Analyzers Market: End Use Segment Dashboard
  • 6.3. End Use Movement & Market Share Analysis, 2024 & 2030
  • 6.4. U.S. Breath Analyzers Market Estimates & Forecast, by End Use
  • 6.5. Law Enforcement Agencies
    • 6.5.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.6. Individuals
    • 6.6.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates & Forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Share/Position Analysis, 2024
  • 7.3. Company Profiles/Listing
    • 7.3.1. Dragerwerk AG & Co. KGaA
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Lifeloc Technologies, Inc.
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Quest Products, LLC.
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Intoximeters
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Alcohol Countermeasure Systems Corp.
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. AK GlobalTech Corp.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. PAS Systems International, Inc
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. BACtrack
      • 7.3.8.1. Overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Lion Laboratories
      • 7.3.9.1. Overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Advanced Safety Devices
      • 7.3.10.1. Overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. MPD, Inc.
      • 7.3.11.1. Overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Abbott Rapid Diagnostics (formerly known as Alere)
      • 7.3.12.1. Overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. AlcoPro
      • 7.3.13.1. Overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. GenWorks Health Pvt. Ltd.
      • 7.3.14.1. Overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦